Status:
COMPLETED
Changing Diabetes® World Tour
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in the Middle East, Northern Africa and Europe. The aim of this study is to contribute to the design of a simple screening strategy for countries in scope, by exploring the ass...
Eligibility Criteria
Inclusion
- Informed consent obtained
Exclusion
- Subjects with known diabetes (exception: women with a history of gestational diabetes should not be excluded)
- Pregnant women or women who have given birth within less than a month
- Subjects suffering from severe illness
- Subjects with the inability to read and understand the information given (either due to illiteracy or vision problems) and therefore unable to give an informed consent
- Subjects with mental impairment
- Subjects treated with systemic cortico-steroids
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
8304 Patients enrolled
Trial Details
Trial ID
NCT01437072
Start Date
November 1 2010
End Date
November 1 2011
Last Update
January 19 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Paço de Arcos, Portugal, 2780-730
2
Novo Nordisk Investigational Site
Riyadh, Saudi Arabia, 3542
3
Novo Nordisk Investigational Site
Dubai, United Arab Emirates